DE1946638A1 - Heterocyclische Verbindungen - Google Patents

Heterocyclische Verbindungen

Info

Publication number
DE1946638A1
DE1946638A1 DE19691946638 DE1946638A DE1946638A1 DE 1946638 A1 DE1946638 A1 DE 1946638A1 DE 19691946638 DE19691946638 DE 19691946638 DE 1946638 A DE1946638 A DE 1946638A DE 1946638 A1 DE1946638 A1 DE 1946638A1
Authority
DE
Germany
Prior art keywords
radical
formula
methyl
denotes
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691946638
Other languages
German (de)
English (en)
Inventor
O'mant Derrick Michael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE1946638A1 publication Critical patent/DE1946638A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19691946638 1968-09-13 1969-09-15 Heterocyclische Verbindungen Pending DE1946638A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4362868 1968-09-13

Publications (1)

Publication Number Publication Date
DE1946638A1 true DE1946638A1 (de) 1970-09-03

Family

ID=10429626

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691946638 Pending DE1946638A1 (de) 1968-09-13 1969-09-15 Heterocyclische Verbindungen

Country Status (5)

Country Link
BE (1) BE738831A (xx)
DE (1) DE1946638A1 (xx)
FR (1) FR2018062B1 (xx)
GB (1) GB1227978A (xx)
NL (1) NL6913673A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047425A1 (en) * 1997-12-17 2000-11-02 Merck & Co., Inc. Integrin receptor antagonists

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4562186A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (1,2,4-Oxadiazol-3-yl)arylmethanones, compositions and pharmaceutical use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047425A1 (en) * 1997-12-17 2000-11-02 Merck & Co., Inc. Integrin receptor antagonists
EP1047425A4 (en) * 1997-12-17 2009-04-22 Merck & Co Inc INTEGRIN RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
FR2018062A1 (xx) 1970-05-29
GB1227978A (xx) 1971-04-15
FR2018062B1 (xx) 1974-01-11
NL6913673A (xx) 1970-03-17
BE738831A (xx) 1970-03-12

Similar Documents

Publication Publication Date Title
DE2524929C3 (de) 2-Hydroxyäthylidencyanessigsäureanilide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel
DE2658610C2 (de) Phenylessigsäureesterderivate
CH618686A5 (xx)
DE1939759A1 (de) Verfahren zur Herstellung von Cyclopropylamin
DE3326164A1 (de) Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE1946638A1 (de) Heterocyclische Verbindungen
DE69707860T2 (de) Verfahren zur herstellung von tetrahydroindolizinen
EP0027268A2 (de) Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung
DE2841644C2 (xx)
DE69516396T2 (de) Verfahren zur herstellung von 3-isoxazol carbonsäure
DE1493797A1 (de) Verfahren zur Herstellung von neuen substituierten Malonsaeuremonohydraziden
DE2560602C2 (de) Sauerstoffhaltige Diarylamidine
DE2618978A1 (de) Verfahren zur herstellung von 1- geschweifte klammer auf eckige klammer auf 5-(4-hydroxy-2h-1,2-benzothiazin- 3-yl)-1,2,4-oxadiazol-3-yl eckige klammer zu methyl geschweifte klammer zu -aethanon- s,s-dioxid sowie bei dem verfahren verwendete zwischenprodukte
DE3718765C2 (xx)
DE2160911A1 (de) Verfahren zur Herstellung von Aminoketonen
DE2412323C3 (de) 1,2-Diphenyl-äthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3641907A1 (de) 4h-benzo(4,5)cyclohepta(1,2-b)thiophen derivate
DE2500840A1 (de) Verfahren zur herstellung von 1h- tetrazol-1-essigsaeure
DE2150146B2 (de) Verfahren zur Herstellung von Flavon-7-oxyessigsäureäthylester
AT326638B (de) Verfahren zur herstellung von n(beta-diäthylaminoäthyl) -4-amino-5-chlor-2-methoxybenzamid
DE2236005C3 (de) Dibenzo- eckige Klammer auf d,f eckige Klammer zu -dioxepin- eckige Klammer auf 1,3 eckige Klammer zu -derivate und deren pharmakologisch verträgliche Salze, sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1620206C (de) N-Cyclopropylmethyl-6,14-endo-äthanotetrahydronororipavine und ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2500919C3 (de) 5-(l-Allyl-2-pyrrolidinylmethylaminocarbonyl)-6-methoxy-benzotriazol sowie seine pharmazeutisch verträglichen Additionssalze mit Säuren
DE2104312C3 (de) (α,α,β,β-Tetrafluorphenäthyl)-α,α-dimethylbenzylaminderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3420387A1 (de) 2-(4-biphenylyl)-4-hexenonsaeure und ihre derivate mit entzuendungshemmender wirksamkeit